These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17142081)

  • 21. Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
    Yeung KS; Yamanaka GA; Meanwell NA
    Med Res Rev; 2006 Jul; 26(4):414-33. PubMed ID: 16521129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
    See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL
    J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.
    Yip MS; Leung HL; Li PH; Cheung CY; Dutry I; Li D; Daëron M; Bruzzone R; Peiris JS; Jaume M
    Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):25-31. PubMed ID: 27390007
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.
    Lin JT; Zhang JS; Su N; Xu JG; Wang N; Chen JT; Chen X; Liu YX; Gao H; Jia YP; Liu Y; Sun RH; Wang X; Yu DZ; Hai R; Gao Q; Ning Y; Wang HX; Li MC; Kan B; Dong GM; An Q; Wang YQ; Han J; Qin C; Yin WD; Dongs XP
    Antivir Ther; 2007; 12(7):1107-13. PubMed ID: 18018769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
    J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a SARS vaccine: an industrial perspective on the global race against a global disease.
    Viret JF; Glück R; Moser C
    Expert Rev Vaccines; 2003 Aug; 2(4):465-7. PubMed ID: 14711331
    [No Abstract]   [Full Text] [Related]  

  • 27. Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.
    Ng OW; Tan YJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):186-189. PubMed ID: 27644155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models for SARS and MERS coronaviruses.
    Gretebeck LM; Subbarao K
    Curr Opin Virol; 2015 Aug; 13():123-9. PubMed ID: 26184451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of severe acute respiratory syndrome (SARS).
    Groneberg DA; Hilgenfeld R; Zabel P
    Respir Res; 2005 Jan; 6(1):8. PubMed ID: 15661082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    Yashavantha Rao HC; Jayabaskaran C
    J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [SARS-CoV: 1. The virus].
    Tratner I
    Med Sci (Paris); 2003; 19(8-9):885-91. PubMed ID: 14593622
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronavirus Proteins as Ion Channels: Current and Potential Research.
    McClenaghan C; Hanson A; Lee SJ; Nichols CG
    Front Immunol; 2020; 11():573339. PubMed ID: 33154751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS and MERS: recent insights into emerging coronaviruses.
    de Wit E; van Doremalen N; Falzarano D; Munster VJ
    Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
    Menachery VD; Yount BL; Josset L; Gralinski LE; Scobey T; Agnihothram S; Katze MG; Baric RS
    J Virol; 2014 Apr; 88(8):4251-64. PubMed ID: 24478444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.
    Venkataraman T; Frieman MB
    Antiviral Res; 2017 Jul; 143():142-150. PubMed ID: 28390872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.
    Tseng CT; Huang C; Newman P; Wang N; Narayanan K; Watts DM; Makino S; Packard MM; Zaki SR; Chan TS; Peters CJ
    J Virol; 2007 Feb; 81(3):1162-73. PubMed ID: 17108019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe acute respiratory syndrome coronavirus protein 6 is required for optimal replication.
    Zhao J; Falcón A; Zhou H; Netland J; Enjuanes L; Pérez Breña P; Perlman S
    J Virol; 2009 Mar; 83(5):2368-73. PubMed ID: 19091867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.